← Back to Search

Doing What Matters in Times of Stress: An Illustrated Guide for Bibliotherapy (DWM Trial)

N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 3 months post-treatment
Awards & highlights

DWM Trial Summary

This trial will investigate whether Twitter can be used to screen and recruit patients with mild-moderate CMDs for a 5-week course of GSH-CBT, and whether social media data can be used to predict engagement, outcomes, and processes in GSH-CBT.

DWM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 3 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 months post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6-week Change in Kessler 6 Psychological Distress Scale (K6)
6-week Change in the WHO 5 Well-being Index (WHO-5)
Secondary outcome measures
3-month Change in Kessler 6 Psychological Distress Scale (K6; 0 - 24)
3-month Change in the WHO 5 Well-being Index (WHO-5)
6-week Change in Emotion Regulation Scale (ERQ) - Reappraisal Subscale
+1 more

DWM Trial Design

1Treatment groups
Experimental Treatment
Group I: Guided self-helpExperimental Treatment1 Intervention
Participants are given access to the World Health Organization's (WHO) "Doing what matters in times of stress: An illustrated guide" (https://www.who.int/publications/i/item/9789240003927) virtually (i.e., as a pdf) and/or in print. Each participant is assigned an "eCoach" -- an undergraduate, post-baccalaureate, or graduate research assistant -- who will meet with the participant for a 60-minute welcome call describing the intervention and 3-6 sessions of guidance focused on promoting adherence to the manual and using skills in everyday life.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Doing What Matters in Times of Stress: An Illustrated Guide
2020
N/A
~270

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
977 Previous Clinical Trials
983,272 Total Patients Enrolled
Indiana Clinical and Translational Sciences InstituteOTHER
18 Previous Clinical Trials
4,517 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,682 Previous Clinical Trials
6,930,657 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities for individuals to participate in this research?

"Clinicaltrials.gov confirms that, since it was last updated on November 15th 2021, this medical trial is not currently accepting any new patients. Though the study has concluded recruitment efforts, 1 other clinical trials are actively seeking participants at present."

Answered by AI

What are the major aims of this investigation?

"This clinical trial's primary objective is to ascertain the 6-week changes in participants' WHO 5 Well-being Index (WHO-5). Secondary goals include assessing 6-week alterations in Emotion Regulation Scale (ERQ) - Reappraisal subscale, ERQ Suppression subscale and 3 months of Kessler Psychological Distress Scale (K6; 0 - 24). The Reappraisal scale evaluates an individual's ability to modify their outlook on emotion inducing stimuli with a score range from 1 - 7 where greater scores reflect more adaptive strategies. Similarly, ERQ Suppression measures maladaptive ways of managing emotions by suppressing thoughts"

Answered by AI

Who else is applying?

What state do they live in?
Indiana
How old are they?
18 - 65
What site did they apply to?
Indiana University
What portion of applicants met pre-screening criteria?
Met criteria
~32 spots leftby Mar 2025